Navidea Biopharmaceuticals Inc (NAVB) stock is lower by -39.16% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives NAVB stock a score of 30 out of a possible 100.
That rank is mainly influenced by a fundamental score of 0. NAVB stock has a mean target price of $5.00. This means analysts expect the stock to add 395.05% over the next 12 months. NAVB's rank also includes a short-term technical score of 31. The long-term technical score for NAVB is 60. NAVB has an Overall Score of 30. Find out what this means to you and get the rest of the rankings on NAVB!